2nd Quarter - Amendment

OGR for MILLENNIUM PHARMACEUTICALS INC

Firm
OGR
Client
Income
$40,000
Expenses
—

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
2nd Quarter - Report Jul 16, 2008 $40,000 Replaced
2nd Quarter - Amendment (this page) Jul 17, 2008 $40,000 Yes

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

S.2499, Medicare, Medicaid, and SCHIP Extension Act of 2007. Issues related to Medicare coverage for certain cancer therapies. Issues related to Comparative Effectiveness.

LobbyistCovered position, as disclosed
MOSES MERCADO —
ANDREW ROSENBERG —
GORDON TAYLOR —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 2499 (110th)

Foreign entities

Foreign owners and affiliates the filer disclosed. Amounts are as declared on this filing.

EntityCountryPrincipal place of businessOwnershipContribution declared
TAKEDA PHARMACEUTICAL COMPANY LIMITED Japan Japan 100.0% —

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.